NCT00400816 Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed Oligoastrocytoma Status COMPLETED Phase PHASE2
NCT00392119 MR Guided Laser Interstitial Thermal Therapy for the "Minimal Invasive" Treatment of Brain Metastasis and Primary Brain Tumors Status COMPLETED Phase PHASE1
NCT00362817 Carboplatin and Temozolomide (Temodar) for Recurrent and Symptomatic Residual Brain Metastases Status COMPLETED Phase PHASE1/PHASE2
NCT00336531 Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation Status COMPLETED Phase PHASE4
NCT00226668 XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema Status WITHDRAWN Phase PHASE3
NCT00226655 An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies Status COMPLETED Phase PHASE3
NCT00180193 F-18-OMFD-PET for Radiotherapy Treatment Planning and Evaluation of Early Therapy Response Status TERMINATED Phase N/A
NCT00178386 Comparison of Educational Services and Outcomes for Patients Treated for Childhood Cancer Status COMPLETED Phase N/A
NCT00147056 MRI-Guided Focused Ultrasound Feasibility Study for Brain Tumors Status ACTIVE_NOT_RECRUITING Phase NA
NCT00088166 XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors Status COMPLETED Phase PHASE3
NCT00085098 Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary Central Nervous System (CNS) Germ Cell Tumor Status COMPLETED Phase PHASE3
NCT00078988 High-Dose Chemotherapy Plus Autologous Stem Cell Transplantation Compared With Intermediate-Dose Chemotherapy Plus Autologous Stem Cell Transplantation With or Without Isotretinoin in Treating Young Patients With Recurrent High-Grade Gliomas Status COMPLETED Phase PHASE3